Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05455294 |
|---|---|
| Brief Title: | Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms |
| First Submitted : | July 5, 2022 |
| First Submitted that Met QC Criteria : | July 7, 2022 |
| First Posted : | July 13, 2022 |
| Last Update Submitted that Met QC Criteria : | July 24, 2023 |
| Last Update Posted : | July 25, 2023 |